Cargando…

A Case of Marburg's Variant of Multiple Sclerosis Successfully Treated with IVIg and Mitoxantrone

Detalles Bibliográficos
Autores principales:	Manuel, Adarsh, Vasudevan, Madabhushi Chakravarthy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061517/ https://www.ncbi.nlm.nih.gov/pubmed/33911391 http://dx.doi.org/10.4103/aian.AIAN_117_20

Ejemplares similares

Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone—A Case Report
por: Capet, Nicolas, et al.
Publicado: (2021)

A Comparative Study of IVIG versus IVIG with IV Methylprednisolone in Guillain–Barre Syndrome
por: Bhattiprolu, Rahi Kiran, et al.
Publicado: (2020)

Case Report: Successful Stabilization of Marburg Variant Multiple Sclerosis With Ocrelizumab Following High-Dose Cyclophosphamide Rescue
por: Koska, Valeria, et al.
Publicado: (2021)

Marburg Virus in Fruit Bat, Kenya
por: Kuzmin, Ivan V., et al.
Publicado: (2010)

Pygmy Populations Seronegative for Marburg Virus
por: Borchert, Matthias, et al.
Publicado: (2005)

Tanzania - The new habitat of Marburg virus
por: Kaifa, Fatema Hasan, et al.
Publicado: (2023)

Successful Treatment of Autoimmune Hemolytic Anemia with Steroid, IVIg, and Plasmapheresis in a Haploidentical Transplant Recipient
por: Uz, Burak, et al.
Publicado: (2012)

Delayed Pneumoventricle Following Endonasal Cerebrospinal Fluid Rhinorrhea Repair with Thecoperitoneal Shunt
por: Krishnan, Shyam Sundar, et al.
Publicado: (2019)

Marburg Virus Disease in Tanzania: The most recent outbreak
por: Deb, Novonil, et al.
Publicado: (2023)

They come in threes: Marburg virus, emerging infectious diseases, and the blood supply()
por: Jacobs, Jeremy W., et al.
Publicado: (2023)

IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration
por: Ruhe, Johannes, et al.
Publicado: (2020)

Malignancies after mitoxantrone for multiple sclerosis: A retrospective cohort study
por: Buttmann, Mathias, et al.
Publicado: (2016)

Cardiotoxicity of Mitoxantrone Treatment in a German Cohort of 639 Multiple Sclerosis Patients
por: Fleischer, Vinzenz, et al.
Publicado: (2014)

Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
por: Zrzavy, Tobias, et al.
Publicado: (2021)

Successful Rapid Desensitization of a Pediatric Multiple Sclerosis Patient with Anaphylaxis to Ocrelizumab
por: Karaaslan, Hatice B. G., et al.
Publicado: (2022)

COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis
por: Mantero, Vittorio, et al.
Publicado: (2020)

COVID-19 in multiple sclerosis patients treated with dimethyl fumarate
por: Capone, Fioravante, et al.
Publicado: (2021)

Mitoxantrone Induces Natural Killer Cell Maturation in Patients with Secondary Progressive Multiple Sclerosis
por: Chanvillard, Coralie, et al.
Publicado: (2012)

Corrigendum to “Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis”
Publicado: (2021)

Digital ulcers secondary to Sneddon’s syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis
por: Barnini, Tommaso, et al.
Publicado: (2012)

Late Cardiotoxicity in MS Patients Treated with Mitoxantrone
por: Najafian, Jamshid, et al.
Publicado: (2019)

Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide
por: Bollo, Luca, et al.
Publicado: (2020)

Mild COVID‐19 infection in a group of teriflunomide‐treated patients with multiple sclerosis
por: Mantero, Vittorio, et al.
Publicado: (2020)

Author response to comment on: Alopecia in multiple sclerosis patients treated with disease modifying therapies
por: Porwal, Mokshal H., et al.
Publicado: (2022)

Reactive perforating collagenosis successfully treated with dupilumab
por: Gil‐Lianes, Javier, et al.
Publicado: (2022)

Seroreactivity against Marburg or related filoviruses in West and Central Africa
por: Steffen, Imke, et al.
Publicado: (2020)

Tourette syndrome and multiple sclerosis: a case report
por: Gondim, Francisco de Assis Aquino, et al.
Publicado: (2023)

Serial Assessment of Cardiac Function during and following Mitoxantrone Infusion in 30 Consecutive Patients with Multiple Sclerosis
por: Franzen, Damian, et al.
Publicado: (2010)

COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
por: Preziosa, Paolo, et al.
Publicado: (2020)

Beta-interferons in multiple sclerosis
por: Aggarwal, Sourabh, et al.
Publicado: (2010)

Neurofibromatosis I and multiple sclerosis
por: Bergqvist, Christina, et al.
Publicado: (2020)

Neuropsychiatric Lupus and Lupus Nephritis Successfully Treated with Combined IVIG and Rituximab: An Alternative to Standard of Care
por: Cheikh, Mohamed M., et al.
Publicado: (2022)

Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report
por: Carrieri, Pietro, et al.
Publicado: (2013)

Adequate antibody response to BioNTech COVID vaccine in a multiple sclerosis patient treated with siponimod
por: Siddiqui, Gulnaz, et al.
Publicado: (2021)

Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study
por: Tabrizi, Nasim, et al.
Publicado: (2012)

Does physical exercise improve or deteriorate treatment of multiple sclerosis with mitoxantrone? Experimental autoimmune encephalomyelitis study in rats
por: El-Emam, Mohamed A., et al.
Publicado: (2022)

Hoarseness: could be presentation of multiple sclerosis?
por: Fatehi, Farzad
Publicado: (2009)

Neuroplasticity in Early Onset Multiple Sclerosis
por: Naser Moghadasi, Abdorreza
Publicado: (2014)

Multiple sclerosis patients and COVID-19
por: Mado, Hubert, et al.
Publicado: (2021)

Tuberous Sclerosis with Multiple Unusual Associations
por: Choudhary, Aakanksha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bd064kt3li7vbtibipk6g0cnlg